Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Menu

    Hydronidone

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gyre Therapeutics Protocol for Phase 3 Trial on F351 in Journal
    Gyre Therapeutics Protocol for Phase 3 Trial on F351 in Journal

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3050406/0/en/Gyre-Therapeutics-Announces-Publication-of-Protocol-for-Phase-3-Trial-Evaluating-F351-for-CHB-Associated-Liver-Fibrosis-in-Journal-of-Clinical-and-Translational-Hepatology.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share
    Gyre Announces Publication in Journal of Gastroenterology and Hepatology
    Gyre Announces Publication in Journal of Gastroenterology and Hepatology

    18 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900811/0/en/Gyre-Therapeutics-Announces-Publication-in-Journal-of-Gastroenterology-and-Hepatology.html

    GLOBENEWSWIRE
    18 Jun 2024
    Share Share